Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Daiichi Sankyo develops LRS inhibitors

Jan. 21, 2016

Spero Therapeutics describes antibacterials

Jan. 21, 2016

Profectus BioSciences initiates phase I testing of a vectored Ebola virus vaccine

Jan. 20, 2016

Sunshine Lake Pharma reports anti-HCV NS5B inhibitors

Jan. 20, 2016

DNAzymes can be used for molecular probes to detect specific bacterial strains

Jan. 20, 2016

First patient dosed in phase I trial evaluating TP-271

Jan. 20, 2016

FDA expands age indication for GSK's Hiberix

Jan. 19, 2016

Biological immunomodulator displays bi-phasic treatment response in preclinical HBV infection model

Jan. 19, 2016

University of Texas System patents agents for African trypanosomiasis

Jan. 15, 2016

Esteve announces sigma1-receptor ligands

Jan. 15, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 25, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026